J. Christopher Naftzger
CIK: 0001496194
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABUS
Arbutus Biopharma Corp
Officer
Discretionary Trading P&L
Holdings
About Naftzger J. Christopher
Naftzger J. Christopher (SEC CIK 0001496194) files insider reports with the SEC as General Counsel and CCO of Arbutus Biopharma Corp (ABUS).
Signal8 holds 2 ownership filings by Naftzger J. Christopher, all Form 4s, filed between Feb 5, 2025 and Feb 19, 2025. Those filings report 2 transactions, from Feb 4, 2025 to Feb 14, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Naftzger J. Christopher's filings is in WARMINSTER, PA.
Recent filings by Naftzger J. Christopher
Other insiders filing for Arbutus Biopharma Corp (ABUS)
- Beardsley Robert A, Director
- Nguyen Tuan, Chief Financial Officer
- Sawhney Roger, Director
- Androski Lindsay, President and CEO
- Hasija Anuj, Director
- Bishop Joseph E, Director